Characteristics and specificity of hybridoma antibodies against oocyst antigens of Cryptosporidium parvum from man
- PMID: 1712929
- DOI: 10.1111/j.1365-3024.1991.tb00280.x
Characteristics and specificity of hybridoma antibodies against oocyst antigens of Cryptosporidium parvum from man
Abstract
Hybridoma antibodies (HAbs) against oocyst antigens of a human isolate of Cryptosporidium parvum were developed by fusion of SP2/0 mouse myeloma cells and spleen cells from BALB/c mice immunized with oocyst homogenates. In an indirect immunofluorescence antibody test (IFAT), using as antigen a mixture of air-dried sporozoites and oocysts, HAbs labelled either the oocyst wall or areas of the sporozoite, including the whole organism, the entire surface, a polar region or the interior. Most of the HAbs were specific for the sporozoite surface, and few of them recognized the oocyst wall. In Western blot analysis of oocyst antigens, sporozoite surface-reactive monoclonal antibodies (MoAbs) recognized one or more of seven polypeptide bands with molecular weights in the range 47- greater than 200 kD, and all reacted with the 47 kD band. Each of four heterologous parasite isolates had a unique recognition pattern with a panel of MoAbs in IFAT, suggesting antigenic differences may exist between strains of C. parvum. The ability to differentiate between parasite isolates by immunological methods might be of value in epidemiological studies of cryptosporidiosis.
Similar articles
-
Analysis of oocyst wall and sporozoite antigens from three Cryptosporidium species.Infect Immun. 1992 Apr;60(4):1509-13. doi: 10.1128/iai.60.4.1509-1513.1992. Infect Immun. 1992. PMID: 1548074 Free PMC article.
-
Comparative study of the antigenic composition of oocyst isolates of Cryptosporidium parvum from different hosts.Parasite Immunol. 1992 Mar;14(2):227-32. doi: 10.1111/j.1365-3024.1992.tb00463.x. Parasite Immunol. 1992. PMID: 1570174
-
Identification of a 15-kilodalton surface glycoprotein on sporozoites of Cryptosporidium parvum.Infect Immun. 1991 Mar;59(3):1002-7. doi: 10.1128/iai.59.3.1002-1007.1991. Infect Immun. 1991. PMID: 1705238 Free PMC article.
-
Molecular targets for detection and immunotherapy in Cryptosporidium parvum.Biotechnol Adv. 2007 Jan-Feb;25(1):13-44. doi: 10.1016/j.biotechadv.2006.08.003. Epub 2006 Aug 30. Biotechnol Adv. 2007. PMID: 17055210 Review.
-
Humoral and cellular immunity against Cryptosporidium infection.Curr Drug Targets Immune Endocr Metabol Disord. 2002 Oct;2(3):291-301. doi: 10.2174/1568008023340505. Curr Drug Targets Immune Endocr Metabol Disord. 2002. PMID: 12476493 Review.
Cited by
-
Neutralization-sensitive epitopes are conserved among geographically diverse isolates of Cryptosporidium parvum.Infect Immun. 1992 Apr;60(4):1703-6. doi: 10.1128/iai.60.4.1703-1706.1992. Infect Immun. 1992. PMID: 1372299 Free PMC article.
-
Rapid antigen detection assay for identification of Chlamydia trachomatis infection.J Clin Microbiol. 1995 Jul;33(7):1920-1. doi: 10.1128/jcm.33.7.1920-1921.1995. J Clin Microbiol. 1995. PMID: 7665671 Free PMC article.
-
Analysis of oocyst wall and sporozoite antigens from three Cryptosporidium species.Infect Immun. 1992 Apr;60(4):1509-13. doi: 10.1128/iai.60.4.1509-1513.1992. Infect Immun. 1992. PMID: 1548074 Free PMC article.
-
Evaluation of an enzyme-linked immunosorbent assay for detection of Cryptosporidium spp. in stool specimens.J Clin Microbiol. 1993 Jun;31(6):1468-71. doi: 10.1128/jcm.31.6.1468-1471.1993. J Clin Microbiol. 1993. PMID: 8314988 Free PMC article.
-
An immunoglobulin G1 monoclonal antibody highly specific to the wall of Cryptosporidium oocysts.Clin Diagn Lab Immunol. 2000 Sep;7(5):745-50. doi: 10.1128/CDLI.7.5.745-750.2000. Clin Diagn Lab Immunol. 2000. PMID: 10973448 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical